spiperone has been researched along with raclopride in 85 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 12 (14.12) | 18.7374 |
1990's | 49 (57.65) | 18.2507 |
2000's | 18 (21.18) | 29.6817 |
2010's | 6 (7.06) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bouthenet, ML; Giros, B; Martres, MP; Schwartz, JC; Sokoloff, P | 1 |
Billings, J; Kung, HF; Kung, MP; Murphy, RA | 1 |
Guo, YZ; Kasliwal, R; Kung, HF; Kung, MP; Mach, RH; Pan, SG | 1 |
Bervoets, K; Brocco, M; Dacquet, C; Girardon, S; Gobert, A; Millan, MJ; Newman-Tancredi, A; Peglion, JL; Rivet, JM; Vian, J | 1 |
Billings, J; Chumpradit, S; Kung, HF; Kung, MP; Mach, R | 1 |
Audinot, V; Chaput, C; Conte, C; Gavaudan, S; Millan, MJ; Newman-Tancredi, A; Touzard, M; Verrièle, L | 1 |
Fang, X; Hu, Z; Levant, B; Min, J; Varady, J; Wang, S; Wu, X | 1 |
Benachour, N; Vanderheyden, PML | 1 |
Civelli, O; Guan, HC; Niznik, HB; Seeman, P; Sunahara, RK; Van Tol, HH | 1 |
Wong, DF | 1 |
Csöregh, I; de Paulis, T; Hall, H; Högberg, T; Lundin, K; Ogren, SO; Stensland, B; Ström, P | 1 |
Inoue, O; Itoh, T; Kobayashi, K; Langstrom, B; Tsukada, H | 1 |
Bengtsson, S; Hall, H; Halldin, C; Högberg, T; Wedel, I | 1 |
Chen, C; Goldman, S; Matsumura, K; Minkin, E; Scheffel, U; Wagner, HN; Wong, DF; Young, LT | 1 |
Ekman, A; Eriksson, E | 1 |
Braff, DL; Geyer, MA; Keith, VA; Swerdlow, NR | 1 |
Farde, L; Hall, H; Halldin, C; Högberg, T; Ohlberger, A; Solin, O; Ström, P | 1 |
Bengtsson, S; de Paulis, T; Hall, H; Högberg, T; Johansson, L; Ogren, SO; Ström, P | 1 |
Andersen, PH; Jansen, JA | 1 |
Farde, L; Hall, H; Halldin, C; Kopp, J; Wedel, I | 1 |
Långström, B | 1 |
Gallager, DW; Goldman-Rakic, PS; Lidow, MS; Rakic, P | 1 |
Guan, HC; Niznik, HB; Seeman, P | 2 |
Lannoye, GS; Moerlein, SM; Parkinson, D; Welch, MJ | 1 |
Dewar, KM; Grondin, L; Montreuil, B; Reader, TA | 1 |
Hidaka, K; Nakamura, Y; Terai, M | 1 |
Hall, H; Sällemark, M | 1 |
Hall, H; Wedel, I | 1 |
Andersen, PH; Nielsen, EB | 1 |
Karlsson-Boethius, G; Köhler, C | 1 |
Andreasen, NC; Carson, R; Diksic, M; Evans, A; Farde, L; Gjedde, A; Hakim, A; Lal, S; Nair, N; Sedvall, G | 1 |
Arnt, J; Hyttel, J; Nowak, G | 1 |
Axelsson, S; Eckernäs, SA; Ekblom, B; Fasth, KJ; Gullberg, P; Hartvig, P; Långström, B; Lindström, L; Lundqvist, H | 1 |
Angeby-Möller, K; de Paulis, T; Hall, H; Johansson, L; Kumar, Y; Ogren, SO; Rämsby, S; Sällemark, M | 1 |
Durcan, MJ; Morgan, PF; Norman, MH; Rigdon, GC | 1 |
Farde, L; Halldin, C; Karlsson, P; Nordström, AL; Nyberg, S; Sedvall, G | 1 |
Asghari, V; Buchwaldt, S; Jovanovic, V; Paterson, A; Sanyal, S; Van Tol, HH | 1 |
Farde, L; Halldin, C; Nordström, AL | 1 |
Nobrega, JN; Seeman, P | 1 |
Korf, J; Vaalburg, W; van der Worp, H; Visser, GM; Wiegman, T; Zijlstra, S | 1 |
Carlsson, A; Haadsma-Svensson, SR; Smith, MW; Svensson, K; Waters, N | 1 |
Guan, HC; Niznik, HB; Seeman, P; Van Tol, HH | 1 |
Fowler, JS; Hitzemann, RJ; MacGregor, RR; Schlyer, DJ; Shea, CE; Volkow, ND; Wang, GJ; Wolf, AP | 1 |
Högberg, T; Jackson, DM; Malmberg, A; Mohell, N; Rosqvist, S; Sällemark, M | 1 |
Fukuda, T; Futamura, T; Haga, K; Ohashi, Y; Takahashi, Y; Yano, K | 1 |
Fowler, JS; Gatley, SJ; Hitzemann, R; Logan, J; MacGregor, RR; Schlyer, DJ; Volkow, ND; Wang, GJ; Wolf, AP | 1 |
Dannals, RF; Kao, PF; Kim, S; Lever, JR; Ravert, HT; Wagner, HN | 1 |
Inoue, O; Kobayashi, K; Långström, B; Onoe, H; Watanabe, Y | 1 |
Creese, I; Florijn, WJ; Tarazi, FI | 1 |
Cravchik, A; Gejman, PV; Hietala, J; Någren, K; Pohjalainen, T; Rinne, J; Syvälahti, E | 1 |
al-Tikriti, MS; Baldwin, RM; Charney, DS; Kessler, RM; Kung, HF; Laruelle, M; Malison, RT; Sybirska, E; Zea-Ponce, Y; Zoghbi, SS | 1 |
Bjurling, P; Fasth, KJ; Hartvig, P; Långström, B; Tedroff, J; Torstenson, R; Watanabe, Y | 1 |
Lima, L; Obregón, F; Urbina, M | 1 |
Fosbraey, P; Kitchen, I; Ridd, MJ | 1 |
Bobirnac, I; Bruinvels, AT; Danzeisen, M; Gazi, L; Geisse, S; Hoyer, D; Schoeffter, P; Schüpbach, E; Sommer, B; Tricklebank, M | 1 |
Bergström, M; Gefvert, O; Hagberg, G; Långström, B; Lindström, L; Wiesel, FA; Wieselgren, IM | 1 |
Gee, A; Hosoi, R; Inoue, O; Kobayashi, K | 1 |
Chu, A; Schetz, JA; Sibley, DR | 1 |
Gee, A; Inoue, O; Kobayashi, K; Wakahara, S | 1 |
Eriksson, B; Farde, L; Halldin, C; Nyberg, S; Oxenstierna, G | 1 |
Endo, K; Hayakawa, N; Ishiwata, K; Oda, K; Ogi, N; Senda, M; Tanaka, A; Toyama, H | 1 |
Kaasinen, V; Lehikoinen, P; Någren, K; Oikonen, V; Rinne, JO; Ruottinen, HM | 1 |
Gee, A; Hosoi, R; Inoue, O; Kobayashi, K; Yamaguchi, M | 1 |
Ferré, S; Finnman, UB; Fuxe, K; Owman, C; Rinken, A; Terasmaa, A | 1 |
Alberts, GL; Im, WB; Pregenzer, JF | 1 |
Armstrong, D; Strange, PG | 1 |
Dewey, SL; Fowler, JS; Gatley, SJ; Logan, J; Volkow, ND | 1 |
Endo, K; Hayakawa, N; Ishiwata, K; Nagaoka, T; Oda, K; Ogi, N; Senda, M; Tanaka, A; Toyama, H; Umegaki, H | 1 |
Gee, A; Hosoi, R; Inoue, O; Ishikawa, M; Kobayashi, K; Yamaguchi, M | 1 |
Ginovart, N; Kapur, S; Ko, F; Seeman, P; Sun, W | 1 |
Hosoi, R; Inoue, O; Ishida, J; Kobayashi, K; Yamaguchi, M | 1 |
Ko, F; Seeman, P; Tallerico, T | 1 |
Cumming, P; Gjedde, A; Jensen, SB; Munk, OL; Olsen, AK; Rosa-Neto, P; Watanabe, H | 1 |
Lin, H; Strange, PG; Vivo, M | 1 |
Durand, CJ; Lan, H; Neve, KA; Teeter, MM | 1 |
Iwata, Y; Minabe, Y; Mori, N; Nakamura, K; Okada, H; Ouchi, Y; Sekine, Y; Sugihara, G; Suzuki, K; Takei, N; Tsuchiya, KJ; Yoshikawa, E | 1 |
Michaelides, M; Piyis, YK; Thanos, PK; Volkow, ND; Wang, GJ | 1 |
Seeman, P | 1 |
De Backer, JP; Packeu, A; Van Liefde, I; Vanderheyden, PM; Vauquelin, G | 1 |
Alstrup, AK; Cumming, P; Doudet, D; Gramsbergen, JB; Jensen, SB; Minuzzi, L; Ostergaard, SD; Pedersen, K | 1 |
De Backer, JP; Packeu, A; Vauquelin, G | 1 |
Ishibashi, K; Ishii, K; Ishiwata, K; Mizusawa, H; Oda, K | 1 |
Nutt, DJ; Parker, CA; Quelch, DR; Tyacke, RJ; Withey, SL | 1 |
Cho, J; Delis, F; Kim, R; Rocco, MJ; Thanos, PK; Volkow, ND | 1 |
3 review(s) available for spiperone and raclopride
Article | Year |
---|---|
Influence of the cellular environment on ligand binding kinetics at membrane-bound targets.
Topics: Angiotensin II Type 1 Receptor Blockers; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Humans; Kinetics; Ligands; Protein Binding; Receptor, Angiotensin, Type 1; Receptors, Cell Surface; Signal Transduction | 2017 |
Design of molecules labeled with beta+ emitters for use in multitracer investigations using positron emission tomography.
Topics: Beta Particles; Humans; Isotope Labeling; Levodopa; Methionine; Neurotransmitter Agents; Nomifensine; Raclopride; Salicylamides; Spiperone; Tomography, Emission-Computed | 1990 |
Workshop on schizophrenia, PET, and dopamine D2 receptors in the human neostriatum.
Topics: Adult; Corpus Striatum; Haloperidol; Humans; National Institute of Mental Health (U.S.); Raclopride; Receptors, Dopamine; Receptors, Dopamine D2; Salicylamides; Schizophrenia; Schizophrenic Psychology; Spiperone; Tomography, Emission-Computed; United States | 1988 |
4 trial(s) available for spiperone and raclopride
Article | Year |
---|---|
High 5-HT2 receptor occupancy in clozapine treated patients demonstrated by PET.
Topics: Adult; Antipsychotic Agents; Clozapine; Dopamine Agonists; Female; Humans; Male; Middle Aged; Prefrontal Cortex; Psychotic Disorders; Raclopride; Receptors, Serotonin; Salicylamides; Schizophrenia; Spiperone; Tomography, Emission-Computed | 1993 |
N-[11C]methylspiperone PET, in contrast to [11C]raclopride, fails to detect D2 receptor occupancy by an atypical neuroleptic.
Topics: Adult; Antipsychotic Agents; Caudate Nucleus; Cerebellum; Dibenzothiazepines; Dopamine; Dose-Response Relationship, Drug; Humans; Male; Putamen; Quetiapine Fumarate; Raclopride; Receptors, Dopamine D2; Salicylamides; Schizophrenia; Spiperone; Tomography, Emission-Computed | 1998 |
Suggested minimal effective dose of risperidone based on PET-measured D2 and 5-HT2A receptor occupancy in schizophrenic patients.
Topics: Adult; Antipsychotic Agents; Basal Ganglia Diseases; Brain; Carbon Radioisotopes; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluorine Radioisotopes; Humans; Male; Psychiatric Status Rating Scales; Raclopride; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D2; Receptors, Serotonin; Risperidone; Salicylamides; Schizophrenia; Schizophrenic Psychology; Spiperone; Tomography, Emission-Computed; Treatment Outcome | 1999 |
Perospirone is a new generation antipsychotic: evidence from a positron emission tomography study of serotonin 2 and D2 receptor occupancy in the living human brain.
Topics: Adult; Antipsychotic Agents; Binding, Competitive; Brain; Humans; Indoles; Isoindoles; Male; Positron-Emission Tomography; Raclopride; Radiopharmaceuticals; Receptors, Dopamine D2; Receptors, Serotonin, 5-HT2; Reference Values; Spiperone; Thiazoles | 2006 |
78 other study(ies) available for spiperone and raclopride
Article | Year |
---|---|
Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics.
Topics: Amino Acid Sequence; Animals; Antipsychotic Agents; Base Sequence; Brain Chemistry; Cell Line; Cloning, Molecular; Cricetinae; DNA; DNA Restriction Enzymes; Dopamine; Guanylyl Imidodiphosphate; Molecular Sequence Data; Nucleic Acid Hybridization; Polymerase Chain Reaction; Rats; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3; RNA, Messenger; Sequence Homology, Nucleic Acid; Tissue Distribution | 1990 |
Synthesis and characterization of iodobenzamide analogues: potential D-2 dopamine receptor imaging agents.
Topics: Animals; Benzofurans; Binding, Competitive; Chemical Phenomena; Chemistry; Corpus Striatum; Iodine Radioisotopes; Isotope Labeling; Male; Molecular Structure; Pyrrolidines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D2; Tissue Distribution | 1990 |
Dopamine D-2 receptor imaging radiopharmaceuticals: synthesis, radiolabeling, and in vitro binding of (R)-(+)- and (S)-(-)-3-iodo-2-hydroxy-6-methoxy-N- [(1-ethyl-2-pyrrolidinyl)methyl]benzamide.
Topics: Animals; Benzamides; Chemical Phenomena; Chemistry; Corpus Striatum; In Vitro Techniques; Iodine Radioisotopes; Male; Pyrrolidines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D2; Stereoisomerism; Structure-Activity Relationship | 1988 |
Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297: 1. Activation of postsynaptic D3 receptors mediates hypothermia, whereas blockade of D2 receptors elicits prolactin
Topics: 2-Naphthylamine; Animals; Body Temperature Regulation; Catalepsy; CHO Cells; Cricetinae; Dopamine Antagonists; Furans; Humans; Male; Prolactin; Rats; Rats, Wistar; Receptors, Dopamine; Receptors, Dopamine D2; Recombinant Proteins; Stereoisomerism | 1995 |
Fluorinated and iodinated dopamine agents: D2 imaging agents for PET and SPECT.
Topics: Animals; Benzamides; Dopamine Agents; Dopamine D2 Receptor Antagonists; Fluorine Radioisotopes; Iodine Radioisotopes; Macaca fascicularis; Male; Pyrrolidines; Radionuclide Imaging; Rats; Rats, Sprague-Dawley; Tissue Distribution; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1993 |
Agonist and antagonist actions of antipsychotic agents at 5-HT1A receptors: a [35S]GTPgammaS binding study.
Topics: Animals; Antipsychotic Agents; CHO Cells; Cricetinae; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin Agents; Sulfur Radioisotopes | 1998 |
Molecular modeling of the three-dimensional structure of dopamine 3 (D3) subtype receptor: discovery of novel and potent D3 ligands through a hybrid pharmacophore- and structure-based database searching approach.
Topics: Algorithms; Binding Sites; Computational Biology; Crystallography, X-Ray; Databases, Protein; Humans; Kinetics; Ligands; Lipid Bilayers; Models, Molecular; Molecular Conformation; Mutation; Receptors, Dopamine D2; Receptors, Dopamine D3; Reproducibility of Results; Solvents; Structure-Activity Relationship; Tetrahydronaphthalenes; Water | 2003 |
The cloned dopamine D2 receptor reveals different densities for dopamine receptor antagonist ligands. Implications for human brain positron emission tomography.
Topics: Antipsychotic Agents; Benzamides; Brain Chemistry; Cloning, Molecular; Dopamine D2 Receptor Antagonists; Humans; Pituitary Gland, Anterior; Raclopride; Receptors, Dopamine D2; Salicylamides; Spiperone; Tomography, Emission-Computed | 1992 |
PET studies of neuroreceptors in schizophrenia. Commentary on "The current status of PET scanning with respect to schizophrenia".
Topics: Brain; Carbon Radioisotopes; Dopamine Antagonists; Humans; Raclopride; Receptors, Dopamine; Receptors, Dopamine D2; Salicylamides; Schizophrenia; Spiperone; Tomography, Emission-Computed; Tritium | 1992 |
Potential antipsychotic agents. 9. Synthesis and stereoselective dopamine D-2 receptor blockade of a potent class of substituted (R)-N-[(1-benzyl-2-pyrrolidinyl)methyl]benzamides. Relations to other side chain congeners.
Topics: Animals; Antipsychotic Agents; Benzamides; Benzyl Compounds; Chemical Phenomena; Chemistry; Corpus Striatum; Dopamine Antagonists; Male; Molecular Conformation; Molecular Structure; Pyrrolidines; Raclopride; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D2; Salicylamides; Spiperone; Stereoisomerism; Structure-Activity Relationship; X-Ray Diffraction | 1991 |
Difference in in vivo receptor binding between [3H]N-methylspiperone and [3H]raclopride in reserpine-treated mouse brain.
Topics: Animals; Cerebellum; Corpus Striatum; Dopamine Agents; Male; Mice; Raclopride; Receptors, Dopamine; Reserpine; Salicylamides; Spiperone | 1991 |
Synthesis and binding properties of the fluorinated substituted benzamide [3H]NCQ 115, a new selective dopamine D2 receptor ligand.
Topics: Animals; Benzamides; Binding, Competitive; Chromatography, High Pressure Liquid; Corpus Striatum; Dopamine Agents; Dopamine Antagonists; In Vitro Techniques; Kinetics; Magnetic Resonance Spectroscopy; Pyrrolidines; Raclopride; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D2; Salicylamides; Sodium; Spiperone; Stereoisomerism | 1991 |
Effects of endogenous dopamine on kinetics of [3H]N-methylspiperone and [3H]raclopride binding in the rat brain.
Topics: Amphetamine; Animals; Brain; Dopamine; Dopamine Antagonists; Kinetics; Male; Raclopride; Rats; Reserpine; Salicylamides; Spiperone; Tomography, Emission-Computed; Tritium | 1991 |
Pituitary and brain D2 receptor density measured in vitro and in vivo in EEDQ treated male rats.
Topics: 4-Butyrolactone; Animals; Brain; Cell Membrane; Corpus Striatum; Kinetics; Limbic System; Male; Pituitary Gland; Quinolines; Raclopride; Radioligand Assay; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D2; Salicylamides; Spiperone; Tritium | 1991 |
Effects of spiperone, raclopride, SCH 23390 and clozapine on apomorphine inhibition of sensorimotor gating of the startle response in the rat.
Topics: Analysis of Variance; Animals; Apomorphine; Benzazepines; Clozapine; Male; Raclopride; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Reflex, Startle; Salicylamides; Schizophrenia; Spiperone | 1991 |
A comparative PET-study of five carbon-11 or fluorine-18 labelled salicylamides. Preparation and in vitro dopamine D-2 receptor binding.
Topics: Animals; Carbon Radioisotopes; Chromatography, High Pressure Liquid; Corpus Striatum; Dopamine Antagonists; Fluorine Radioisotopes; In Vitro Techniques; Isotope Labeling; Macaca fascicularis; Male; Potentiometry; Raclopride; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D2; Salicylamides; Spiperone; Tomography, Emission-Computed | 1991 |
Potential antipsychotic agents 5. Synthesis and antidopaminergic properties of substituted 5,6-dimethoxysalicylamides and related compounds.
Topics: Animals; Antipsychotic Agents; Apomorphine; Binding Sites; Chemical Phenomena; Chemistry; Dopamine Antagonists; Male; Raclopride; Rats; Rats, Inbred Strains; Salicylamides; Spiperone; Structure-Activity Relationship | 1990 |
Dopamine receptor agonists: selectivity and dopamine D1 receptor efficacy.
Topics: Adenosine Triphosphate; Adenylyl Cyclases; Animals; Benzazepines; Blood-Brain Barrier; Corpus Striatum; Dopamine Agents; Guanosine Triphosphate; In Vitro Techniques; Male; Raclopride; Rats; Rats, Inbred Strains; Receptors, Dopamine; Salicylamides; Spiperone; Stimulation, Chemical; Structure-Activity Relationship | 1990 |
Comparison of the in vitro receptor binding properties of N-[3H]methylspiperone and [3H]raclopride to rat and human brain membranes.
Topics: Animals; Binding, Competitive; Brain; Corpus Striatum; Dopamine; Dopamine Agents; Dopamine Antagonists; Humans; Male; Membranes; Putamen; Raclopride; Rats; Salicylamides; Spiperone; Tritium | 1990 |
Distribution of dopaminergic receptors in the primate cerebral cortex: quantitative autoradiographic analysis using [3H]raclopride, [3H]spiperone and [3H]SCH23390.
Topics: Animals; Benzazepines; Brain Mapping; Cerebral Cortex; Ketanserin; Macaca mulatta; Mianserin; Raclopride; Receptors, Dopamine; Salicylamides; Species Specificity; Spiperone | 1991 |
Elevation of dopamine D2 receptors in schizophrenia is underestimated by radioactive raclopride.
Topics: Animals; Brain; Carbon Radioisotopes; Caudate Nucleus; Cerebellum; Corpus Striatum; Dopamine; Dopamine Antagonists; Humans; Putamen; Raclopride; Receptors, Dopamine; Salicylamides; Schizophrenia; Spiperone; Tomography, Emission-Computed; Tritium | 1990 |
N-fluoroalkylated and N-alkylated analogues of the dopaminergic D-2 receptor antagonist raclopride.
Topics: Animals; Brain; Dopamine Antagonists; Female; Ligands; Macaca nemestrina; Male; Raclopride; Radiochemistry; Rats; Rats, Inbred Strains; Receptors, Dopamine; Salicylamides; Spiperone | 1990 |
Endogenous dopamine lowers the dopamine D2 receptor density as measured by [3H]raclopride: implications for positron emission tomography of the human brain.
Topics: Animals; Corpus Striatum; Dopamine; Humans; Raclopride; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D2; Salicylamides; Spiperone; Tomography, Emission-Computed | 1989 |
Dopamine D2 receptors labeled with [3H]raclopride in rat and rabbit brains. Equilibrium binding, kinetics, distribution and selectivity.
Topics: Animals; Binding, Competitive; Corpus Striatum; Kinetics; Male; Rabbits; Raclopride; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D2; Salicylamides; Sodium; Species Specificity; Spiperone; Tritium | 1989 |
Comparison of [3H]YM-09151-2 with [3H]spiperone and [3H]raclopride for dopamine d-2 receptor binding to rat striatum.
Topics: Animals; Antipsychotic Agents; Benzamides; Corpus Striatum; Kinetics; Male; Raclopride; Rats; Rats, Inbred Strains; Receptors, Dopamine; Salicylamides; Spiperone | 1989 |
Effects of chronic neuroleptic treatment on agonist affinity states of the dopamine-D2 receptor in the rat brain.
Topics: Animals; Antipsychotic Agents; Benzamides; Binding, Competitive; Brain Chemistry; Guanylyl Imidodiphosphate; Kinetics; Male; Raclopride; Rats; Rats, Inbred Strains; Receptors, Dopamine; Remoxipride; Salicylamides; Spiperone | 1987 |
Comparisons between the in vitro binding of two substituted benzamides and two butyrophenones to dopamine-D2 receptors in the rat striatum.
Topics: Animals; Benzamides; Butyrophenones; Corpus Striatum; Domperidone; In Vitro Techniques; Ketanserin; Kinetics; Male; Piperidines; Raclopride; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D2; Salicylamides; Spiperone; Sulpiride | 1986 |
The benzazepine, SCH 23390, inhibits 3H-NPA binding in mouse brain in vivo.
Topics: Animals; Apomorphine; Benzazepines; Binding, Competitive; Male; Mice; Raclopride; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Salicylamides; Spiperone | 1986 |
In vivo labelling of rat brain dopamine D-2 receptors. Stereoselective blockade by the D-2 antagonist raclopride and its enantiomer of 3H-spiperone, 3H-N,N-propylnorapomorphine and 3H-raclopride binding in the rat brain.
Topics: Animals; Apomorphine; Binding, Competitive; Brain; Kinetics; Male; Organ Specificity; Raclopride; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D2; Salicylamides; Spiperone; Stereoisomerism | 1988 |
EEDQ, a tool for ex vivo measurement of occupancy of D-1 and D-2 dopamine receptors.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Corpus Striatum; Ergolines; In Vitro Techniques; Male; Quinolines; Quinpirole; Raclopride; Rats; Rats, Inbred Strains; Receptors, Dopamine; Salicylamides; Spiperone | 1988 |
Receptor binding and selectivity of three 11C-labelled dopamine receptor antagonists in the brain of rhesus monkeys studied with positron emission tomography.
Topics: Animals; Brain; Clozapine; Female; Macaca mulatta; Raclopride; Receptors, Dopamine; Salicylamides; Spiperone; Tissue Distribution; Tomography, Emission-Computed | 1988 |
Potential neuroleptic agents. 4. Chemistry, behavioral pharmacology, and inhibition of [3H]spiperone binding of 3,5-disubstituted N-[(1-ethyl-2-pyrrolidinyl)methyl]-6-methoxysalicylamides.
Topics: Animals; Apomorphine; Chemical Phenomena; Chemistry; Corpus Striatum; Haloperidol; Male; Raclopride; Rats; Rats, Inbred Strains; Receptors, Dopamine; Salicylamides; Spiperone; Stereotyped Behavior; Structure-Activity Relationship | 1986 |
Is clozapine selective for the dopamine D4 receptor?
Topics: Binding Sites; Cell Membrane; Clozapine; Dopamine Antagonists; Dose-Response Relationship, Drug; Humans; Raclopride; Receptors, Dopamine D2; Salicylamides; Spiperone | 1995 |
D1, D2, and 5-HT2 receptor occupancy in relation to clozapine serum concentration: a PET study of schizophrenic patients.
Topics: Adult; Benzazepines; Brain; Clozapine; Female; Humans; Male; Middle Aged; Raclopride; Receptors, Dopamine; Receptors, Serotonin; Salicylamides; Schizophrenia; Spiperone; Tomography, Emission-Computed; Treatment Outcome | 1995 |
Modulation of intracellular cyclic AMP levels by different human dopamine D4 receptor variants.
Topics: Animals; Benzamides; Cell Line; CHO Cells; Clozapine; Colforsin; Cricetinae; Cyclic AMP; Dinoprostone; Dopamine; Haloperidol; HeLa Cells; Humans; Raclopride; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Dopamine D4; Recombinant Proteins; Salicylamides; Spiperone; Transfection | 1995 |
Dopamine D2 receptors mapped in rat brain with [3H](+)PHNO.
Topics: Animals; Autoradiography; Brain; Brain Chemistry; Brain Mapping; Densitometry; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Guanine Nucleotides; Guanylyl Imidodiphosphate; In Vitro Techniques; Ligands; Male; Oxazines; Raclopride; Rats; Rats, Wistar; Salicylamides; Spiperone | 1994 |
Synthesis and in vivo distribution in the rat of a dopamine agonist: N-([11C]methyl)norapomorphine.
Topics: Animals; Apomorphine; Brain; Carbon Radioisotopes; Dopamine Agents; Kidney; Liver; Lung; Male; Raclopride; Rats; Rats, Wistar; Receptors, Dopamine D2; Salicylamides; Spiperone | 1993 |
The dopamine D3-receptor: a postsynaptic receptor inhibitory on rat locomotor activity.
Topics: Aminoquinolines; Animals; Apomorphine; CHO Cells; Corpus Striatum; Cricetinae; Dextroamphetamine; Dopamine; Dopamine Antagonists; Drug Interactions; Indans; Male; Methyltyrosines; Models, Biological; Motor Activity; Nucleus Accumbens; Raclopride; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Recombinant Fusion Proteins; Reserpine; Salicylamides; Spiperone; Stimulation, Chemical | 1993 |
Low density of dopamine D4 receptors in Parkinson's, schizophrenia, and control brain striata.
Topics: Animals; Benzamides; Corpus Striatum; Dopamine D2 Receptor Antagonists; Humans; In Vitro Techniques; Kinetics; Parkinson Disease; Pituitary Gland, Anterior; Pyrrolidines; Raclopride; Rats; Receptors, Dopamine; Receptors, Dopamine D4; Salicylamides; Schizophrenia; Spiperone; Swine; Tomography, Emission-Computed | 1993 |
Comparison of two PET radioligands for imaging extrastriatal dopamine receptors in the human brain.
Topics: Adult; Brain; Carbon Radioisotopes; Fluorine Radioisotopes; Humans; Kinetics; Male; Middle Aged; Organ Specificity; Pituitary Gland; Raclopride; Radioligand Assay; Receptors, Dopamine; Reference Values; Salicylamides; Spiperone; Tomography, Emission-Computed | 1993 |
Binding characteristics of remoxipride and its metabolites to dopamine D2 and D3 receptors.
Topics: Animals; Cell Line; Cloning, Molecular; Corpus Striatum; Fibroblasts; Humans; Mice; Raclopride; Radioligand Assay; Rats; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Dopamine D3; Remoxipride; Salicylamides; Spiperone | 1993 |
[The affinities of mosapramine for the dopamine receptor subtypes in human cell lines expressing D2, D3 and D4 receptors].
Topics: Antipsychotic Agents; Benzazepines; Cell Line; Clozapine; Haloperidol; Humans; Raclopride; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D4; Receptors, Dopamine D5; Risperidone; Salicylamides; Spiperone | 1996 |
Measuring age-related changes in dopamine D2 receptors with 11C-raclopride and 18F-N-methylspiroperidol.
Topics: Adult; Age Factors; Aged; Aging; Cerebellum; Corpus Striatum; Dopamine Agonists; Female; Humans; Ligands; Male; Middle Aged; Nerve Degeneration; Raclopride; Receptors, Dopamine D2; Salicylamides; Spiperone; Tomography, Emission-Computed | 1996 |
Assessing neuroreceptor occupancy by continuous infusion of carbon-11 labeled radioligands.
Topics: Adult; Brain; Carbon Radioisotopes; Dopamine Agonists; Dopamine Antagonists; Fentanyl; Humans; Infusion Pumps; Male; Raclopride; Radioligand Assay; Radionuclide Imaging; Receptors, Opioid; Salicylamides; Spiperone | 1996 |
Difference in response of D2 receptor binding between 11C-N-methylspiperone and 11C-raclopride against anesthetics in rhesus monkey brain.
Topics: Anesthetics; Animals; Brain; Carbon Radioisotopes; Dopamine Agonists; Dopamine Antagonists; Female; Isoflurane; Ketamine; Macaca mulatta; Raclopride; Receptors, Dopamine D2; Salicylamides; Spiperone; Tomography, Emission-Computed | 1995 |
Dopamine receptor subtypes: differential regulation after 8 months treatment with antipsychotic drugs.
Topics: Animals; Antipsychotic Agents; Benzamides; Benzazepines; Brain; Clozapine; Corpus Striatum; Haloperidol; Iodine Radioisotopes; Male; Organ Specificity; Raclopride; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Receptors, Serotonin; Salicylamides; Spiperone; Tetrahydronaphthalenes; Time Factors; Tritium; Up-Regulation | 1997 |
Antagonist binding characteristics of the Ser311-->Cys variant of human dopamine D2 receptor in vivo and in vitro.
Topics: Adult; Aged; Aged, 80 and over; Animals; CHO Cells; Cricetinae; Cysteine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Female; Heterozygote; Humans; Male; Middle Aged; Protein Binding; Raclopride; Radioligand Assay; Receptors, Dopamine D2; Salicylamides; Serine; Spiperone | 1997 |
Comparison of three high affinity SPECT radiotracers for the dopamine D2 receptor.
Topics: Animals; Benzamides; Benzofurans; Brain; Contrast Media; Dextroamphetamine; Dopamine Agents; Female; Iodine Radioisotopes; Papio; Pyrrolidines; Raclopride; Receptors, Dopamine D2; Ritanserin; Salicylamides; Serotonin Antagonists; Spiperone; Tissue Distribution; Tomography, Emission-Computed, Single-Photon | 1994 |
Amphetamine effects on dopamine release and synthesis rate studied in the Rhesus monkey brain by positron emission tomography.
Topics: Amphetamine; Animals; Brain; Cerebrovascular Circulation; Decarboxylation; Dopamine; Dopamine Agents; Dopamine Agonists; Dopamine Antagonists; Female; Levodopa; Macaca mulatta; Raclopride; Salicylamides; Spiperone; Tomography, Emission-Computed | 1997 |
[3H]raclopride and [3H]spiroperidol binding to retinal membranes of the teleost Eugerres plumieri: effect of light and dark adaptation.
Topics: Adaptation, Ocular; Animals; Binding Sites; Dark Adaptation; Dopamine; Dopamine Antagonists; Fishes; Membranes; Raclopride; Retina; Salicylamides; Spiperone; Tritium | 1997 |
The effect of acute kainic acid treatment on dopamine D2 receptors in rat brain.
Topics: Animals; Brain; Iodine Radioisotopes; Isotope Labeling; Kainic Acid; Male; Neurons; Protein Binding; Raclopride; Rats; Rats, Wistar; Receptors, Dopamine D2; Salicylamides; Spiperone; Sulpiride; Tritium | 1998 |
The agonist activities of the putative antipsychotic agents, L-745,870 and U-101958 in HEK293 cells expressing the human dopamine D4.4 receptor.
Topics: Aminopyridines; Antipsychotic Agents; Cell Line; Clozapine; Colforsin; Cyclic AMP; Dopamine; Dopamine Agonists; Dopamine Antagonists; Humans; Kidney; Piperidines; Pyridines; Pyrroles; Raclopride; Receptors, Dopamine D2; Receptors, Dopamine D4; Recombinant Proteins; Salicylamides; Spiperone | 1998 |
Changes in apparent in vivo binding of [3H]raclopride and [3H]N-methylspiperone induced by oxotremorine.
Topics: Animals; Brain; Male; Mice; Mice, Inbred Strains; Muscarinic Agonists; Muscarinic Antagonists; Oxotremorine; Raclopride; Radioligand Assay; Receptors, Dopamine D2; Salicylamides; Scopolamine; Spiperone; Tritium | 1998 |
Zinc modulates antagonist interactions with D2-like dopamine receptors through distinct molecular mechanisms.
Topics: Algorithms; Animals; CHO Cells; Colforsin; Cricetinae; Cyclic AMP; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Kinetics; Raclopride; Radioligand Assay; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, Dopamine D4; Salicylamides; Sodium; Spiperone; Thermodynamics; Zinc | 1999 |
Enhancement of 3H-N-methylspiperone binding but not 3H-raclopride binding in mouse striatum by MK-801: evidence that factors other than competition by endogenous dopamine are responsible for changes in D2 receptor binding in vivo. Short communication.
Topics: Animals; Binding Sites; Cerebellum; Cerebral Cortex; Dizocilpine Maleate; Dopamine; Dopamine Agonists; Dopamine Antagonists; Kinetics; Mice; Models, Biological; Neostriatum; Raclopride; Receptors, Dopamine D2; Salicylamides; Spiperone | 1999 |
Comparison of three PET dopamine D2-like receptor ligands, [11C]raclopride, [11C]nemonapride and [11C]N-methylspiperone, in rats.
Topics: Animals; Benzamides; Brain; Cerebellum; Dopamine Agonists; Dopamine Antagonists; Ligands; Male; Raclopride; Rats; Rats, Wistar; Receptors, Dopamine D2; Salicylamides; Spiperone; Tissue Distribution; Tomography, Emission-Computed; Visual Cortex | 1999 |
Upregulation of putaminal dopamine D2 receptors in early Parkinson's disease: a comparative PET study with [11C] raclopride and [11C]N-methylspiperone.
Topics: Carbon Radioisotopes; Dopamine Agonists; Dopamine Antagonists; Female; Humans; Male; Middle Aged; Parkinson Disease; Putamen; Raclopride; Receptors, Dopamine D2; Spiperone; Tomography, Emission-Computed; Up-Regulation | 2000 |
Discrepancies in apparent dopamine D2 receptor occupancy between 3H-raclopride and 3H-N-methylspiperone.
Topics: Animals; Binding Sites; Binding, Competitive; Brain Chemistry; Male; Mice; Raclopride; Radioligand Assay; Receptors, Dopamine D2; Spiperone; Tritium | 1999 |
Modulation of [(35)S]GTPgammaS binding to chinese hamster ovary cell membranes by D(2(short)) dopamine receptors.
Topics: Animals; Binding, Competitive; Butaclamol; CHO Cells; Cricetinae; Dopamine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Guanosine 5'-O-(3-Thiotriphosphate); Guanosine Diphosphate; Membranes; Raclopride; Radioligand Assay; Rats; Receptors, Dopamine D2; Spiperone; Sulfur Radioisotopes; Tritium | 2000 |
Advantages of heterologous expression of human D2long dopamine receptors in human neuroblastoma SH-SY5Y over human embryonic kidney 293 cells.
Topics: Calcium Channels; Cells, Cultured; Cloning, Molecular; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Heterotrimeric GTP-Binding Proteins; Humans; Kidney; Neuroblastoma; Neurons; Raclopride; Receptors, Dopamine D2; Recombinant Proteins; Spiperone; Tumor Cells, Cultured | 2000 |
Dopamine D2 receptor dimer formation: evidence from ligand binding.
Topics: Animals; CHO Cells; Cricetinae; Dimerization; Dopamine Antagonists; Ligands; Raclopride; Radioligand Assay; Receptors, Dopamine D2; Spiperone; Tritium | 2001 |
A consideration of the dopamine D2 receptor monomer-dimer equilibrium and the anomalous binding properties of the dopamine D2 receptor ligand, N-methyl spiperone.
Topics: Animals; Binding Sites; Brain; Brain Chemistry; Dimerization; Dopamine Antagonists; Kinetics; Ligands; Models, Biological; Papio; Raclopride; Receptors, Dopamine D2; Spiperone; Tomography, Emission-Computed | 2001 |
Positron emission tomography and ex vivo and in vitro autoradiography studies on dopamine D2-like receptor degeneration in the quinolinic acid-lesioned rat striatum: comparison of [11C]raclopride, [11C]nemonapride and [11C]N-methylspiperone.
Topics: Animals; Autoradiography; Benzamides; Dopamine Antagonists; Glucose; Magnetic Resonance Imaging; Male; Neostriatum; Neurotoxins; Quinolinic Acid; Raclopride; Radiopharmaceuticals; Rats; Rats, Wistar; Receptors, Dopamine D2; Receptors, GABA-A; Spiperone; Tomography, Emission-Computed | 2002 |
Effects of rolipram on in vivo dopamine receptor binding.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Benzazepines; Binding Sites; Brain; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Male; Mice; Neurons; Phosphodiesterase Inhibitors; Raclopride; Radioligand Assay; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Rolipram; Spiperone | 2002 |
In vivo evidence for dopamine-mediated internalization of D2-receptors after amphetamine: differential findings with [3H]raclopride versus [3H]spiperone.
Topics: Amphetamine; Animals; Binding Sites; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Endocytosis; Guanylyl Imidodiphosphate; Male; Raclopride; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Spiperone; Subcellular Fractions; Time Factors; Tritium | 2003 |
Effect of sabcomeline on muscarinic and dopamine receptor binding in intact mouse brain.
Topics: Animals; Brain; Cerebellum; Cerebral Cortex; Corpus Striatum; Diagnostic Techniques, Radioisotope; Dose-Response Relationship, Drug; Imines; Male; Metabolic Clearance Rate; Mice; Mice, Inbred Strains; Organ Specificity; Piperidines; Protein Binding; Quinuclidines; Quinuclidinyl Benzilate; Raclopride; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Dopamine; Spiperone; Tissue Distribution; Tritium | 2003 |
Dopamine displaces [3H]domperidone from high-affinity sites of the dopamine D2 receptor, but not [3H]raclopride or [3H]spiperone in isotonic medium: Implications for human positron emission tomography.
Topics: Animals; Domperidone; Dopamine; Dopamine Antagonists; Isotonic Solutions; Raclopride; Rats; Receptors, Dopamine D2; Sodium; Spiperone; Tomography, Emission-Computed; Tritium | 2003 |
MDMA-evoked changes in [11C]raclopride and [11C]NMSP binding in living pig brain.
Topics: Animals; Binding Sites; Binding, Competitive; Brain; Carbon Radioisotopes; Cerebrovascular Circulation; Corpus Striatum; Dopamine; Down-Regulation; Drug Interactions; Female; N-Methyl-3,4-methylenedioxyamphetamine; Presynaptic Terminals; Raclopride; Radioligand Assay; Receptors, Dopamine D2; Serotonin; Spiperone; Sus scrofa; Tomography, Emission-Computed | 2004 |
Investigation of cooperativity in the binding of ligands to the D(2) dopamine receptor.
Topics: Animals; Benzamides; Cell Line; Dopamine Antagonists; Ligands; Protein Binding; Raclopride; Radioligand Assay; Receptors, Dopamine D2; Spiperone | 2006 |
Structural determinants of pharmacological specificity between D(1) and D(2) dopamine receptors.
Topics: Alternative Splicing; Animals; Benzazepines; Cell Line; Dopamine Antagonists; Models, Molecular; Mutation; Protein Conformation; Raclopride; Radioligand Assay; Rats; Receptors, Dopamine D1; Receptors, Dopamine D2; Solvents; Spiperone; Sulpiride | 2006 |
Food restriction markedly increases dopamine D2 receptor (D2R) in a rat model of obesity as assessed with in-vivo muPET imaging ([11C] raclopride) and in-vitro ([3H] spiperone) autoradiography.
Topics: Age Factors; Animals; Apomorphine; Appetite Regulation; Autoradiography; Brain; Disease Models, Animal; Dopamine; Dopamine Agonists; Eating; Food Deprivation; In Vitro Techniques; Male; Motor Activity; Obesity; Positron-Emission Tomography; Raclopride; Rats; Rats, Zucker; Receptors, Dopamine D2; Receptors, Leptin; Spiperone; Tritium | 2008 |
Dopamine D2(High) receptors on intact cells.
Topics: Adenoma; Animals; Binding, Competitive; Corpus Striatum; Domperidone; Dopamine Antagonists; Pituitary Neoplasms; Raclopride; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Spiperone | 2008 |
Antagonist-radioligand binding to D2L-receptors in intact cells.
Topics: Animals; CHO Cells; Computer Simulation; Cricetinae; Cricetulus; Deuterium; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Humans; Ligands; Raclopride; Radioligand Assay; Receptors, Dopamine D2; Spiperone; Time Factors | 2008 |
MDMA-evoked changes in the binding of dopamine D(2) receptor ligands in striatum of rats with unilateral serotonin depletion.
Topics: Animals; Autoradiography; Binding, Competitive; Carbon Radioisotopes; Corpus Striatum; Dopamine Antagonists; Hallucinogens; Image Processing, Computer-Assisted; Ligands; Male; N-Methyl-3,4-methylenedioxyamphetamine; Positron-Emission Tomography; Raclopride; Radioligand Assay; Radiopharmaceuticals; Rats; Rats, Inbred Lew; Receptors, Dopamine D2; Serotonin; Spiperone | 2010 |
Non-competitive interaction between raclopride and spiperone on human D-receptors in intact Chinese hamster ovary cells.
Topics: Animals; Binding Sites; Binding, Competitive; CHO Cells; Cricetinae; Cricetulus; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Humans; Raclopride; Receptors, Dopamine D2; Spiperone | 2010 |
Competition between 11C-raclopride and endogenous dopamine in Parkinson's disease.
Topics: Aged; Binding, Competitive; Carbon Radioisotopes; Case-Control Studies; Dopamine; Female; Humans; Linear Models; Male; Middle Aged; Neostriatum; Nortropanes; Parkinson Disease; Positron-Emission Tomography; Raclopride; Reproducibility of Results; Retrospective Studies; Spiperone; Synapses | 2010 |
The influence of different cellular environments on PET radioligand binding: an application to D2/3-dopamine receptor imaging.
Topics: Animals; Cell Membrane; Corpus Striatum; Dopamine D2 Receptor Antagonists; Endosomes; Extracellular Space; Kinetics; Male; Positron-Emission Tomography; Raclopride; Radioligand Assay; Radiopharmaceuticals; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, Dopamine D3; Spiperone; Subcellular Fractions; Tritium | 2014 |
Effects of chronic methamphetamine on psychomotor and cognitive functions and dopamine signaling in the brain.
Topics: Animals; Anxiety; Benzazepines; Body Weight; Brain; Carbon Isotopes; Central Nervous System Stimulants; Cognition; Dopamine; Dopamine Antagonists; Dopamine Plasma Membrane Transport Proteins; Exploratory Behavior; Male; Methamphetamine; Psychomotor Performance; Raclopride; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Recognition, Psychology; Signal Transduction; Spiperone | 2017 |